Why Moisture Testing Matters for ODF Films and Tablets
Share
In ODF films, tablets, and other solid dosage forms, moisture content is a critical factor influencing product stability, mouthfeel, and shelf life. Excessive moisture may cause softening, sticking, or microbial risks, while too little moisture can lead to cracking and inconsistent dosing. As a result, moisture analysis is an essential part of both pharmaceutical and functional food production.
1. Why Is Moisture Testing So Important?
- Ensures storage stability: Keeps the product structurally sound across various humidity and temperature conditions.
- Optimizes formulation: Water content affects film flexibility and disintegration time.
- Required by pharmacopeias: All major pharmacopeias include moisture specifications for oral solids.
2. Common Issues in Moisture Testing
- Reliance on subjective methods: Some manufacturers still judge moisture by touch or visual cues.
- Delayed feedback: Traditional oven drying methods are time-consuming and unsuited for in-process adjustments.
- Overlooking batch variability: Inadequate sampling can lead to out-of-spec batches going undetected.
3. Industry Trends
- Fast electronic testing: Modern moisture analyzers replace outdated oven methods for faster turnaround.
- High-sensitivity sensors: Capable of handling ultra-thin ODFs and small tablets.
- Smart calibration: Advanced devices offer auto-calibration for improved accuracy and consistency.
4. Huanghai’s Moisture Testing Solution
- HY-310 Electronic Moisture Analyzer: Designed for ODFs, tablets, and powders with high-speed, accurate results.
- Rapid testing: Delivers results within minutes—ideal for batch QC or in-line sampling.
- Easy to use and maintain: Low cost of ownership and fully GMP compliant.
View Product: HY-310 Electronic Moisture Analyzer
Conclusion
Moisture analysis may seem like a small step, but it's a crucial part of ensuring the long-term stability and regulatory compliance of ODF films and tablets. Choosing a reliable, pharma-grade moisture analyzer can significantly reduce risks and boost production confidence—especially for facilities aiming at international markets.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJ180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJ180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
For a full overview of the certifications and compliance standards our equipment meets, see our Certifications & Compliance page.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from lab-scale R&D (BY-300A / MJ150-L) to commercial manufacturing (MJ150). GMP-certified and 21 CFR Part 11 compliant.